Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NM-101
DRUG
2 trials
Sponsors
Neuramedy Co. Ltd.
Conditions
Healthy Subjects
Parkinson Disease
Phase 1
Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101
NCT05790382
Neuramedy Co. Ltd.
Parkinson Disease
Start: 2023-05-10
End: 2024-06-14
Target: 56
Updated: 2023-03-30
Phase 1 Single Ascending Dose Study
Recruiting
NCT06934941
Neuramedy Co. Ltd.
Healthy Subjects
Start: 2024-11-25
End: 2026-03-30
Target: 36
Updated: 2025-04-18